Peter MacCallum Cancer Centre has announced a new Sister Institution Agreement with the Fudan University Shanghai Cancer Centre (FUSCC) in China. The Agreement was signed in Shanghai today by FUSCC President, Xiaomao Guo, MD and Peter Mac Chief Executive, Ms Dale Fisher.

Under the Agreement, Peter Mac and FUSCC will establish a partnership focused on: physician education and training, including clinical exchange in high-technology areas such as robotic surgery, with a focus on uro-oncology; Research collaborations in cutting-edge fields of molecular and genomic medicine and immunology; and education and training for clinician scientists, laboratory scientists, nurses and support teams.

The agreement further supports Victoria’s International Health Strategy launched in July this year, which encourages local health organisations to develop strategic relationships with global partners while positioning Victoria for economic and health care opportunities internationally.

Minister for Health Jill Hennessy said the agreement reinforced Victoria's reputation as a world leader in health and medical research.

"Through our International Health Strategy we are collaborating with the very best and brightest medical research minds from around the world to deliver better outcomes for Victorian patients and drive economic growth and innovation," said Ms Hennessy.

"This is yet another opportunity to share our knowledge and learn from others as we work together in the global fight against cancer."

According to Ms Fisher, the Agreement is a further demonstration of how major cancer centres globally are uniting as never before in their quest for cancer cures.

“We are delighted to partner with Fudan University Shanghai Cancer Centre in our mission to accelerate our cancer research and translate these discoveries into new cancer care therapies." 

“The Agreement builds on existing international collaborations such as Peter Mac’s Sister Institute Agreement with M.D Anderson Cancer Centre at Texas Medical Centre which was established in 2014.

“We’ve experienced first-hand how these networks can facilitate capability-building and the rapid exchange of clinical and scientific knowledge to benefit patients of both Centres but also all people affected by cancer,” said Ms Fisher.

Ms Fisher was joined in Shanghai by Peter Mac’s Chief Medical Officer, Mr David Speakman, and Associate Professor Declan Murphy Urologist & Director of Genitourinary Oncology at Peter Mac.

Victoria’s International Health Strategy 2016-2020 promotes Victoria’s health system to international markets by strengthening ties and building new links; developing new sources of revenue for our health services; and encourages service delivery and research partnerships.